___

• 1. Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altıparmak MR et al. A population-based survey of Chronic Renal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant 2011; 26(6): 1862-71.
• 2. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004; 52(11): 1863-9.
• 3. Amatneeks TM, Hamdan AC. Montreal Cognitive Assessment for cognitive assessment in chronic kidney disease: a systematic review. J Bras Nefrol 2019; 41(1): 112-23.
• 4. Akkus G, Seyithanoglu M, Akkus H, Ulu S, Ciftcioglu M, Erken E et al. Serum NT-proBNP levels are associated with cognitive functions in hemodialysis patients. Semin Dial 2021; 34(2): 170-5.
• 5. Hannan M, Steffen A, Quinn L, Collins EG, Phillips SA, Bronas UG. The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review. J Nephrol 2019; 32(2): 211-30.
• 6. Ak R, Üstündağ S, Üstündağ A, Güldiken B, Süt N. Kronik Böbrek Hastalığında Bilişsel Fonksiyon Bozukluğu: Diyaliz Modalitesinin Etkisi. Turk Neph Dial Transpl 2015; 24(3): 283-93.
• 7. Selekler K, Cangöz B, Uluc S. Montreal Bilişsel Değerlendirme Ölçeği (MOBİD)’ nin hafif bilişsel bozukluk ve Alzheimer hastalarının ayırt edebilme gücünün incelenmesi. Turkish Journal of Geriatrics 2010; 13(3): 166-71.
• 8. Avcı Gülen HK, Yıldırım A, Emre U, Karagöz Y, Arda Akbaş E. Hafif bilişsel bozuklukta MOBİD ölçek puanlari ile bilişsel duzey korelasyonunun değerlendirilmesi. İstanbul Med J 2017; 18: 18-22.
• 9. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4): 695-9.
• 10. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 2013; 126(3): 256–63.
• 11. Sugimura Y, Takagi H, Mizoguchi H, Mizoguchi H, Takeuchi H, Izumida H et al. Chronic Hyponatremia Causes Neurologic and Psychologic Impairments. J Am Soc Nephrol 2016; 27(3): 766-80.
• 12. Lim LM, Tsai NC, Lin MY, Hwang DY, Lin HY, Lee JJ et al. Hyponatremia is associated with fluid imbalance and adverse renal outcome in chronic kidney disease patients treated with diuretics. Sci Rep 2016: 14; 6: 36817.
• 13. Xu R, Pi HC, Xiong ZY, Liao JL, Hao L, Liu GL et al. Hyponatremia and cognitive impairment in patients treated with peritoneal dialysis. Clin J Am Soc Nephrol 2015: 7; 10(10): 1806-13.
• 14. Shavit L, Mikeladze I, Torem C, Slotki I. Mild hyponatremia is associated with functional and cognitive decline in chronic hemodialysis patients. Clin Nephrol 2014; 82(5): 313-9.
• 15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 (Suppl 1):S5–S20.
• 16. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al. Hyponatraemia guideline development group. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014: 25; 170(3): G1-47.
• 17. Şengül HS, Şengül Y, Yücel S, Forta H. Cognitive Impairment in young multiple sclerosis and essential tremor patients: a comparative study. Turk J Neurol 2016; 22: 109-13.
• 18. Aksoy S, Timer E, Mumcu S, Akgün M, Kıvrak E, Örken Necioğlu D. Multipl sklerozda bilişsel etkilenmenin MOBİD ölçeği ile taranmasi. Turkish Jour Neurol 2013; 19(2): 52-5.
• 19. Bozacı İ, Tatar E. Comparison of the Frequency and Severity of Depression Between Patients with stage 4 and 5 Chronic kidney disease with and without kidney transplantation. Med Bull Haseki 2020; 58: 376-81.
• 20. Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol 2020: 16(8): 452-69.
• 21. Paraizo Mde A, Almeida AL, Pires LA, Abrita RS, Crivellari MH, Pereira Bdos S et al. Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis. J Bras Nefrol 2016; 38(1): 31-41. English, Portuguese.
• 22. Georgakis MK, Dimitriou NG, Karalexi MA, Mihas C, Nasothimiou EG, Tousoulis D et al. Albuminuria in association with cognitive function and dementia: a systematic review and meta-analysis. J Am Geriatr Soc 2017; 65(6): 1190-8.
• 23. Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol 2011; 34(1): 49-54.
• 24. Stivelman JC. Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant 2000;15 Suppl 3:29-35.
• 25. Afsar B. Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis. Clin Exp Nephrol 2013; 17(1): 59-65.
• 26. Afsar B, Elsurer R. Association between serum bicarbonate and pH with depression, cognition and sleep quality in hemodialysis patients. Ren Fail 2015l; 37(6): 957-60.
• 27. Filippatos TD, Makri A, Elisaf MS, Liamis G. Hyponatremia in the elderly: challenges and solutions. Clin Interv Aging 2017; 12: 1957-65.
• 28. Holland-Bill L, Christiansen CF, Heide-Jorgensen U, Ulrichsen SP, Ring T, Jorgensen JO et al. Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. Eur J Endocrinol 2015; 173(1): 71-81.
• 29. Afsar B. The relationship between cognitive function, depressive behaviour and sleep quality with 24-h urinary sodium excretion in patients with essential hypertension. High Blood Press Cardiovasc Prev 2013; 20(1): 19-24.
• 30. Fujisawa H, Sugimura Y, Takagi H, Mizoguchi H, Takeuchi H, Izumida H et al. Chronic hyponatremia causes neurologic and psychologic impairments. J Am Soc Nephrol 2016; 27(3): 766-80.
• 31. Verbalis JG, Ellison H, Hobart M, Krasa H, Ouyang J, Czerwiec FS ; Investigation of the neurocognitive impact of sodium improvement in geriatric hyponatremia: efficacy and safety of tolvaptan (INSIGHT) investigators. tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: A Randomized Trial (INSIGHT). Am J Kidney Dis 2016; 67(6): 893-901.
• 32. Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res 1991; 20; 567(2): 274-82.
• 33. Haskew-Layton RE, Rudkouskaya A, Jin Y, Feustel PJ, Kimelberg HK, Mongin AA. Two distinct modes of hypoosmotic medium-induced release of excitatory amino acids and taurine in the rat brain in vivo. PLoS One 2008; 3(10): e3543.
• 34. Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R et al. Kidney function and cognitive impairment in US adults: the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis 2008; 52(2): 227-34.
• 35. Alagiakrishnan K, Zhao N, Mereu L, Senior P, Senthilselvan A. Montreal Cognitive Assessment is superior to Standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int 2013; 2013: 186106.
• 36. Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci 2002; 15; 203-204: 147-51.
• 37. Hajjar I, Okafor M, McDaniel D, Obideen M, Dee E, Shokouhi M et al. Effects of Candesartan vs Lisinopril on neurocognitive function in older adults with executive mild cognitive impairment: a randomized clinical trial. JAMA Netw Open 2020; 3; 3(8): e2012252.
• 38. Beydoun MA, Hossain S, Fanelli-Kuczmarski MT, Beydoun HA, Canas JA, Evans MK et al. Vitamin D status and intakes and their association with cognitive trajectory in a longitudinal study of urban adults. J Clin Endocrinol Metab 2018; 103(4): 1654–68.